Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,189.5
-12.3 (-0.39%)

 

  • STI Straits Times Index
    3,189.5
    -12.3 (-0.39%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,586.3
    -1.7 (-0.11%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,106.8
    -25.3 (-0.10%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,619.0
    9.1 (0.25%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,127.5
    527.1 (1.84%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,625.7
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 390.8M
  • Value: 242.9M
  • Rise: 85
  • Fall: 106
  • Unch: 560

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.091+0.002
Hatten Land0.065+0.002
Beverly JCG0.001-
Mermaid Maritime0.106+0.010
Net Pacific Fin0.035+0.001
Sinjia Land0.103+0.003
ThaiBev0.710-
QT Vascular0.006+0.001
Rex Intl0.350-0.010
Thomson Medical0.088-0.001

World Indices

World Indices
Name Last Change
Nasdaq 15,226.7 +136.5
HSI 26,115.5 -16.5
HSCEI 9,307.3 -14.8
Jakarta 6,625.7
Nikkei 225 29,128.1 +527.7
SSE Comp 3,619.1 +9.2
Shanghai A 3,793.0 +9.7
Shanghai B 277.0 +0.4
KOSPI 3,037.9 +17.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

LKL LKL INTERNATIONAL BERHAD
Quotes 15 Minutes Delayed. Updated at 26 Oct 2021 09:46
Last (MYR): 0.125 Change: - High: 0.130 Remarks:
Change (%): - Low: 0.125
Open 0.125 Yesterday's Close 0.125
Buy Price 0.125 Sell Price 0.130
Buy Volume ('00) 7,419 Sell Volume ('00) 13,783
Cumulative Volume ('00) 15,977 Cumulative Value 200,138
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a -0.00453 Trailing EPS (MYR) e -0.00856 NAV (MYR) b 0.2739
PE a - Trailing PE f - Price / NAV b 0.4564
Dividend (MYR) d - Cash In Hand (MYR) g 0.0496 Issued & Paid-up Shares c 773,110,600
Dividend Yield (%) d - Price / Cash In Hand g 2.520 Treasury Shares h -
Beta - 75 Daysi 1.165 R-Squared - 75 Days(%)i 7.23 Market Cap (M) 96.639
Beta - 500 Daysi 2.235 R-Squared - 500 Days (%)i 6.54 Enterprise Value (M) 66.485
Piotroski F Score 2 Exchange Code 0182 Par Value ( $ ) n.a.
52 Weeks Volatility (%) 65.35 6-Month VWAP 0.336 Free Float (%) 75.7
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Medical Specialties
Index Components BM HEALTH CARE
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 13 Sep 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Sep 2021.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference LKL Bursa 96.639 - - 0.4564 -
Industry HEALTH CARE EQUIPMENT & SERVICES Bursa 6,939.063 3.523 2.764 3.0830 13.599
Medical Specialties Bursa 8,120.926 3.346 2.934 2.7653 14.549
Index BM HEALTH CARE Bursa 7,296.246 7.613 5.669 2.7466 6.498
Local Peer TOPGLOV Bursa 22,093.415 2.807 2.807 3.6624 24.182
Local Peer HARTA Bursa 20,402.248 7.071 4.142 3.1242 8.560
Local Peer SUPERMX Bursa 5,078.220 1.332 1.332 1.0681 -
Local Peer RGTBHD Bursa 419.443 41.888 41.886 4.1016 -
Local Peer ADVENTA Bursa 154.314 - - 2.4951 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 239,100.397 37.506 27.815 6.4878 0.146
Global Peer ABBOTT LABORATORIES NYSE 224,403.556 50.168 31.081 - 1.208
Global Peer DANAHER CORP NYSE 218,732.020 62.317 47.499 -66.9320 0.234
Global Peer MEDTRONIC PLC NYSE 166,288.284 46.114 42.825 3.2298 1.877
Global Peer INTUITIVE SURGICAL INC NASDAQ 122,652.009 115.644 72.610 10.7487 -
Global Peer STRYKER CORP NYSE 102,966.063 64.394 49.432 7.4505 0.860
Global Peer EDWARDS LIFESCIENCES CORP NYSE 73,116.374 88.798 49.998 14.2436 -
Global Peer BECTON DICKINSON & CO NYSE 70,766.488 92.264 37.944 2.9324 1.295
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,347.086 - 135.357 3.9736 -
Global Peer IDEXX LABORATORIES INC NASDAQ 55,513.726 95.421 76.271 74.2698 -
Other Global Peers DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), BAXTER INTERNATIONAL INC (NYSE), ALCON AG (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), WATERS CORP (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), ABIOMED INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), MASIMO CORPORATION (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), NOVOCURE LTD (NASDAQ), QIAGEN NV (NYSE), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), MICROPORT SCIENTIFIC CORPORATION (HKEx), GLOBUS MED INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), SHANDONG WEIGAO GROUP MEDICAL (HKEx), SHOCKWAVE MEDICAL INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), ANGELALIGN TECHNOLOGY INC (HKEx), STEVANATO GROUP S.P.A. (NYSE), INMODE LTD (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), QUIDEL CORP (NASDAQ), Top Glove (SGX), ICU MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), INARI MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), LIVANOVA PLC (NASDAQ), CONMED CORP (NYSE), NEVRO CORP (NYSE), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), CAREDX INC (NASDAQ), HAEMONETICS CORP (NYSE), THE BEAUTY HEALTH COMPANY (NASDAQ), ATRICURE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VENUS MEDTECH (HANGZHOU) INC (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), LIFETECH SCIENTIFIC CORP (HKEx), GLAUKOS CORPORATION (NYSE), SILK ROAD MEDICAL INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), ESTABLISHMENT LABS HLDGS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), PEIJIA MEDICAL LIMITED (HKEx), AVANOS MEDICAL INC (NYSE), MESA LABORATORIES INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), KANGJI MEDICAL HLDGS LTD (HKEx), PULMONX CORPORATION (NASDAQ), CUE HEALTH INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), PARAGON 28 INC (NYSE), NANOSONICS LIMITED (ASX), ATRION CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), AK MEDICAL HLDGS LTD (HKEx), ALPHATEC HLDGS INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), VICARIOUS SURGICAL INC (NYSE), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), 908 DEVICES INC (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), INOGEN INC (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), DERMTECH INC (NASDAQ), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), BIOVENTUS INC (NASDAQ), SISRAM MEDICAL LTD (HKEx), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), MODERN DENTAL GROUP LIMITED (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), SURMODICS INC (NASDAQ), CUTERA INC (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), SI BONE INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), INTERCURE LTD (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ANTARES PHARMA INC (NASDAQ), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), AXOGEN INC (NASDAQ), NYXOAH SA (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), VAPOTHERM INC (NYSE), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), PAVMED INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), IRADIMED CORP (NASDAQ), MISONIX INC (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), SOLITON INC (NASDAQ), STEREOTAXIS INC (NYSE American), ZYNEX INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), LUCID DIAGNOSTICS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), NEUROPACE INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), SIENTRA INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), INCANNEX HEALTHCARE LTD (ASX), CVRX INC (NASDAQ), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), ONCOCYTE CORP (NASDAQ), EARGO INC (NASDAQ), AROA BIOSURGERY LTD (ASX), TALIS BIOMEDICAL CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), QUOTIENT LTD (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), PW MEDTECH GROUP LIMITED (HKEx), CYTOSORBENTS CORP (NASDAQ), CONFORMIS INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), LUCIRA HEALTH INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), IMPEDIMED LIMITED (ASX), TITAN MEDICAL INC (NASDAQ), TELA BIO INC (NASDAQ), CORMEDIX INC (NASDAQ), INVACARE CORP (NYSE), INTRICOM CORP (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), UGHealthcare (SGX), ENLIVEX THERAPEUTICS LTD (NASDAQ), Medtecs Intl (SGX), ATOMO DIAGNOSTICS LIMITED (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), NEURONETICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), KELFRED HOLDINGS LTD (HKEx), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), IRIDEX CORP (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), MICRO-X LTD (ASX), CRYO-CELL INTERNATIONAL INC (NASDAQ), FONAR CORP (NASDAQ), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), OPTISCAN IMAGING (ASX), ENVVENO MED CORP (NASDAQ), ALPHA PRO TECH (NYSE American), SDI LTD (ASX), ELECTROMED INC (NYSE American), VOLITIONRX LIMITED (NYSE American), BIOSIG TECHNOLOGIES INC (NASDAQ), BIOLASE INC (NASDAQ), CHECK-CAP LTD (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), LENSAR INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), CELSION CORPORATION (NASDAQ), VINCENT MEDICAL HOLDINGS LTD (HKEx), NEPHROS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), IMMUCELL CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), AVINGER INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ELECTROCORE INC (NASDAQ), DIMERIX LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), BIOMERICA INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), NEOVASC INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), COMPUMEDICS (ASX), APPLIED UV INC (NASDAQ), CARDIEX LTD (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), YUNNAN ENERGY INTL CO LTD (HKEx), DAXOR CORP (NYSE American), TENAX THERAPEUTICS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), Biolidics (SGX), KEWAUNEE SCIENTIFIC CORP (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), NUTRIBAND INC (NASDAQ), RESPIRI LTD (ASX), Yunnan Energy (SGX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), INSPIREMD INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), LIFE HEALTHCARE GROUP LTD (HKEx), PLUS THERAPEUTICS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), VIVEVE MEDICAL INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), RA MEDICAL SYSTEMS INC (NYSE American), OVENTUS MEDICAL LTD (ASX), NUWELLIS INC (NASDAQ), ADHERIUM LIMITED (ASX), TRUSCREEN GROUP LTD (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), CYANOTECH CORP (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), INSPIRA TECH OXY BHN LTD (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), METALICITY LIMITED (ASX), USCOM LTD (ASX), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.025
-16.67 %
10 Days --0.035
-21.88 %
20 Days --0.075
-37.50 %
Medium Term Return 3 Months --0.160
-56.14 %
6 Months --0.225
-64.29 %
1 Year --0.895
-87.75 %
Long Term Return 2 Years -+0.030
+31.58 %
3 Years --0.010
-7.41 %
5 Years 0.004-0.140
-51.32 %
Annualised Return Annualised --
-13.41 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.120 - 1.100 Change From 1 Year Low +0.005 % Change From 1 Year Low (%) +4.17
Change From 1 Year High -0.975 % Change From 1 Year High (%) -88.64
2 Years Range 0.085 - 2.020 Change From 2 Years Low +0.040 % Change From 2 Years Low (%) +47.06
Change From 2 Years High -1.895 % Change From 2 Years High (%) -93.81
5 Years Range 0.085 - 2.020 Change From 5 Years Low +0.040 % Change From 5 Years Low (%) +47.06
Change From 5 Years High -1.895 % Change From 5 Years High (%) -93.81
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

IPO Performance

Listing Date 16 May 2016 Full Subscription Rate (x) -
No of Placement Shares (M) 42.00 No of Public Offer Shares (M) 113.00 Public Offer Subscription Rate (x) -
IPO Price (MYR) 0.200 First Day Close (MYR) 0.280 First Week Close (MYR) 0.275
Current vs IPO Price (%) -37.50 First Day Gain (%) +40.00 First Week Gain (%) +37.50

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Apr 2019 Part 1(2.46 MB)
Annual Report 2018 Apr 2018 Part 1(0.48 MB)
Part 2(1.53 MB)
Part 3(0.96 MB)
Part 4(0.35 MB)
Annual Report 2017 Apr 2017 Part 1(2.81 MB)
Annual Report 2016 Apr 2016 Part 1(0.08 MB)
Part 2(2.13 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
25 Oct 2021 0.135 0.135 0.120 0.125 65,547,600 0.1255
22 Oct 2021 0.140 0.145 0.135 0.135 3,525,700 0.1370
21 Oct 2021 0.145 0.145 0.140 0.145 17,274,100 0.1404
20 Oct 2021 0.150 0.150 0.145 0.145 4,355,200 0.1454
18 Oct 2021 0.155 0.155 0.145 0.150 42,813,200 0.1493
15 Oct 2021 0.160 0.165 0.155 0.155 3,646,800 0.1560
14 Oct 2021 0.160 0.165 0.155 0.160 40,892,500 0.1600
13 Oct 2021 0.165 0.175 0.155 0.160 57,581,800 0.1655
12 Oct 2021 0.160 0.170 0.155 0.165 43,800,900 0.1643
11 Oct 2021 0.170 0.170 0.155 0.160 6,269,000 0.1609
08 Oct 2021 0.160 0.165 0.155 0.165 6,741,100 0.1604
07 Oct 2021 0.170 0.170 0.160 0.160 8,614,400 0.1626
06 Oct 2021 0.175 0.180 0.170 0.170 3,279,200 0.1722
05 Oct 2021 0.175 0.180 0.170 0.170 5,792,300 0.1744
04 Oct 2021 0.190 0.190 0.175 0.180 8,565,700 0.1806
01 Oct 2021 0.205 0.205 0.185 0.190 11,257,000 0.1952
30 Sep 2021 0.205 0.210 0.200 0.200 12,466,600 0.2052
29 Sep 2021 0.210 0.210 0.200 0.210 4,985,500 0.2058
28 Sep 2021 0.205 0.210 0.200 0.210 13,042,900 0.2029
27 Sep 2021 0.210 0.210 0.200 0.200 7,627,300 0.2041
24 Sep 2021 0.205 0.215 0.205 0.205 5,428,800 0.2101
23 Sep 2021 0.205 0.210 0.205 0.205 2,792,000 0.2083
Summary
Current 2 Weeks
(11 Oct 2021 to 25 Oct 2021)
0.170 0.175 0.120 0.125 285,706,800 -
Previous 2 Weeks
(27 Sep 2021 to 08 Oct 2021)
0.210 0.210 0.120 0.165 82,372,000 -
4 Weeks from
(26 Aug 2021 to 24 Sep 2021)
0.250 0.250 0.120 0.205 159,993,900 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.